Peter Hur, PharmD

Pfizer Inc.

Poster(s):

• P4373 - Understanding Patient Preferences at the Time of Treatment Escalation to First Line Advanced Therapies in Ulcerative Colitis: A Discrete Choice Experiment in Five European Countries
  Tuesday, October 29, 2024

  10:30 AM – 4:00 PM ET

• P4374 - Understanding Gastroenterologist Preferences at the Time of Treatment Escalation to First-Line Advanced Therapies in Ulcerative Colitis: A Discrete Choice Experiment in Five European Countries
  Tuesday, October 29, 2024

  10:30 AM – 4:00 PM ET

• P4375 - Matching-Adjusted Indirect Comparison of Etrasimod Versus Ozanimod for Clinical Response and Remission Among Patients With Moderately to Severely Active Ulcerative Colitis
  Tuesday, October 29, 2024

  10:30 AM – 4:00 PM ET